We are live on
!
Find out more
CII
CR Intrinsic Investors Portfolio holdings
AUM
$2.67B
1-Year Est. Return
28.43%
This Fund
S&P 500
This Quarter
Est. Return
+1.99%
1 Year Est. Return
+28.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.67B
AUM Growth
+$363M
(+16%)
Cap. Flow
+$333M
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
15.66%
Holding
393
New
127
Increased
67
Reduced
60
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$41.2M |
| 2 |
Intuitive Surgical
ISRG
|
+$40.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$37M |
| 4 |
CVSA
Covista Inc
CVSA
|
+$36.7M |
| 5 |
Boston Scientific
BSX
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$38.6M |
| 2 |
Charter Communications
CHTR
|
+$38.3M |
| 3 |
Goodyear
GT
|
+$34.3M |
| 4 |
Owens Corning
OC
|
+$29.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.06% |
| 2 | Healthcare | 17.09% |
| 3 | Industrials | 9.3% |
| 4 | Consumer Staples | 5.77% |
| 5 | Technology | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Fossil Group
FOSL
$260M
| $5.83M | 0.22% |
50,000
-36,000
| -42% | -$4.19M |
|
|
EXAM
152
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $5.81M | 0.22% |
165,900
+40,800
| +33% | +$1.32M |
|
153
Artisan Partners
APAM
$2.86B
| $5.78M | 0.22% |
+90,000
| New | +$5.79M |
|
154
Snap-on
SNA
$21.5B
| $5.67M | 0.21% |
+50,000
| New | +$5.41M |
|
155
PUT
Humana
HUM
$43.9B
| $5.64M | 0.21% |
+50,000
| New | +$5.21M |
|
|
MDRX
156
DELISTED
Veradigm Inc. Common Stock
MDRX
| $5.59M | 0.21% |
310,000
-50,000
| -14% | -$865K |
|
|
BGG
157
DELISTED
Briggs & Stratton Corp.
BGG
| $5.56M | 0.21% |
250,000
+200,000
| +400% | +$4.36M |
|
158
Dick's Sporting Goods
DKS
$18.4B
| $5.46M | 0.2% |
+100,000
| New | +$5.41M |
|
159
SBA Communications
SBAC
$19.8B
| $5.46M | 0.2% |
+60,000
| New | +$5.56M |
|
160
CALL
Estee Lauder
EL
$30.4B
| $5.35M | 0.2% |
+80,000
| New | +$5.56M |
|
161
Fidelity National Financial
FNF
$14.4B
| $5.34M | 0.2% |
+297,759
| New | +$5.38M |
|
|
PNRA
162
DELISTED
Panera Bread Co
PNRA
| $5.29M | 0.2% |
30,000
-56,650
| -65% | -$10M |
|
163
Yum! Brands
YUM
$41.9B
| $5.28M | 0.2% |
+97,370
| New | +$5.13M |
|
|
QLIK
164
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $5.21M | 0.2% |
196,008
-368,392
| -65% | -$10.3M |
|
|
RESI
165
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $5.21M | 0.2% |
165,000
+121,500
| +279% | +$3.67M |
|
166
CALL
Bristol-Myers Squibb
BMY
$129B
| $5.2M | 0.19% |
+100,000
| New | +$5.32M |
|
167
Invesco
IVZ
$12.4B
| $5.18M | 0.19% |
140,000
-5,000
| -3% | -$173K |
|
168
HealthStream
HSTM
$863M
| $5.17M | 0.19% |
193,835
+8,835
| +5% | +$262K |
|
169
Acco Brands
ACCO
$399M
| $5.13M | 0.19% |
833,208
+696,191
| +508% | +$4.27M |
|
|
SPLK
170
DELISTED
Splunk Inc
SPLK
| $5.08M | 0.19% |
71,001
-130,000
| -65% | -$10.6M |
|
171
Kirby Corp
KEX
$7.01B
| $5.06M | 0.19% |
50,000
-50,000
| -50% | -$5.04M |
|
|
ATHN
172
DELISTED
Athenahealth, Inc.
ATHN
| $4.97M | 0.19% |
31,001
-20,000
| -39% | -$3.29M |
|
|
GNC
173
DELISTED
GNC Holdings, Inc.
GNC
| $4.84M | 0.18% |
110,000
-19,000
| -15% | -$940K |
|
174
PPG Industries
PPG
$24.9B
| $4.84M | 0.18% |
50,000
+10,000
| +25% | +$949K |
|
175
Pfizer
PFE
$143B
| $4.82M | 0.18% |
+158,100
| New | +$4.71M |
|
Similar funds
SCM
SZC
RM
HOAM
SC
G
TT
IPRC
CR Intrinsic Investors's Q1 2014 Portfolio in Review
As of Q1 2014, CR Intrinsic Investors held 393 positions worth $2.67B, up 16% from $2.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
CR Intrinsic Investors deployed $333M of net new capital in Q1 2014, opening 127 new positions and adding to 67 existing holdings. Its largest new stake was Cigna: 500,000 shares worth $41.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Goodyear, an estimated $34.3M trimmed.
- CR Intrinsic Investors's largest Q1 2014 buy was Cigna: 500,000 shares worth $41.9M.
- CR Intrinsic Investors added most to Boston Scientific in Q1 2014, an estimated $26.3M increase.
- CR Intrinsic Investors's biggest Q1 2014 reduction was Goodyear, cutting an estimated $34.3M.
- CR Intrinsic Investors fully exited Crown Castle in Q1 2014, selling an estimated $38.6M.
- CR Intrinsic Investors's ten largest holdings make up 16% of its $2.67B portfolio in Q1 2014.
- CR Intrinsic Investors opened 127 new positions and closed 135 in Q1 2014.
- CR Intrinsic Investors's portfolio value rose 16% quarter-over-quarter to $2.67B.
Based on CR Intrinsic Investors's 13F filing for Q1 2014, filed 15 May 2014.